According to TipRanks, Katkhuda is a 5-star analyst with an average return of 32.4% and a 58.62% success rate. Katkhuda covers the Healthcare sector, focusing on stocks such as Disc Medicine, MoonLake Immunotherapeutics, and Eledon Pharmaceuticals.
Veradermics, Incorporated has an analyst consensus of Strong Buy, with a price target consensus of $169.20.
Based on Veradermics, Incorporated’s latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $27.23 million. In comparison, last year the company had a GAAP net loss of $5.66 million
